[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:basal-cell-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":203,"states":204},"Basal Cell Carcinoma",31,23,[8,16,22,28,35,42,48,54,61,67,73,79,85,91,97,103,109,115,121,127,133,139,145,151,158,165,172,178,184,191,197],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07227870","L19IL2\u002FTNF in Patients With Basal Cell Carcinoma",[12],"Phase 2","RECRUITING","2026-08-26T02:15:54.846520Z","2026-07-24T01:27:14.897082Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07227350","L19IL2 or L19TNF or L19IL2\u002FTNF in Patients With Basal Cell Carcinoma (BCC)",[12],"2026-08-26T02:15:41.377360Z","2026-07-19T19:36:05.069488Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06624475","Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma",[12],"2026-08-26T02:17:10.213717Z","2026-05-05T02:43:29.060910Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT05651828","Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma",[32],"Early Phase 1","2026-08-26T02:15:09.079045Z","2026-05-05T02:43:28.902688Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT06623201","Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas",[39],"Phase 1","2026-08-26T02:15:37.042762Z","2026-05-05T02:43:28.793368Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06344052","To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma",[12],"2026-08-26T02:17:33.807405Z","2026-05-05T02:43:28.360440Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT03521830","Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma",[12],"2026-08-26T02:18:04.640417Z","2026-05-05T02:43:27.249229Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":59,"content_modified":60},"NCT07010692","Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment",[58],"Phase 1\u002FPhase 2","2026-08-26T02:18:52.966503Z","2026-05-05T02:43:28.292794Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06398418","R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors",[39],"2026-08-26T02:16:46.951087Z","2026-05-05T02:43:26.728386Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT05533697","Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors",[58],"2026-08-26T02:19:04.543908Z","2026-05-05T02:43:29.371442Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT05859074","A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer",[39],"2026-08-26T02:16:32.589113Z","2026-05-05T02:43:27.807952Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[12],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT05725291","AMT-116 in Patients With Advanced Solid Tumors",[39],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:26.924853Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT05086692","A Beta-only IL-2 ImmunoTherapY Study",[58],"2026-08-26T02:18:31.164304Z","2026-05-05T02:35:31.708594Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT05896839","Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer",[58],"2026-08-26T02:19:11.399072Z","2026-05-05T02:35:31.620913Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT07286318","A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients",[32],"2026-08-26T02:17:30.145302Z","2026-05-05T02:43:27.065852Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT07182240","Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas",[],"2026-08-26T02:18:20.384845Z","2026-05-05T02:43:29.409770Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT06473103","Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy",[],"2026-08-26T02:17:16.126291Z","2026-05-05T02:43:28.205978Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT06384924","Raman Spectroscopy and Skin Cancer",[],"2026-08-26T02:18:21.216897Z","2026-05-13T02:55:06.485949Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT07215988","Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a \"Filter\" Observational Study",[],"2026-08-26T02:15:25.633039Z","2026-07-05T05:32:16.664484Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT07241585","Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)",[],"2026-08-26T02:18:56.409949Z","2026-05-05T02:43:27.758346Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT07285044","The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas",[12],"2026-08-26T02:16:24.135291Z","2026-07-05T05:32:16.672723Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT07628634","Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w\u002F Solid Tumors",[32],"2026-08-26T02:18:00.873391Z","2026-06-06T00:48:49.527814Z",{"nct_id":152,"title":153,"phases":154,"status":156,"updated_at":149,"content_modified":157},"NCT05212246","Basal Cell Carcinoma Chemoprevention Trial",[155],"Phase 3","NOT_YET_RECRUITING","2026-05-05T02:43:29.676655Z",{"nct_id":159,"title":160,"phases":161,"status":162,"updated_at":163,"content_modified":164},"NCT03503240","Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:26.640202Z","2026-06-16T05:54:07.967134Z",{"nct_id":166,"title":167,"phases":168,"status":169,"updated_at":170,"content_modified":171},"NCT07144384","Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma",[32],"ACTIVE_NOT_RECRUITING","2026-08-03T03:41:15.134818Z","2026-05-05T02:43:28.500399Z",{"nct_id":173,"title":174,"phases":175,"status":169,"updated_at":176,"content_modified":177},"NCT06539468","Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients",[],"2026-08-03T02:02:51.511154Z","2026-05-05T02:43:27.856579Z",{"nct_id":179,"title":180,"phases":181,"status":169,"updated_at":182,"content_modified":183},"NCT05020912","Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy",[12],"2026-08-03T02:42:01.977337Z","2026-05-05T02:35:31.753633Z",{"nct_id":185,"title":186,"phases":187,"status":188,"updated_at":189,"content_modified":190},"NCT06409195","A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers",[12],"UNKNOWN","2026-08-03T03:38:13.938630Z","2026-05-05T02:43:28.655616Z",{"nct_id":192,"title":193,"phases":194,"status":169,"updated_at":195,"content_modified":196},"NCT05378425","A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab",[39],"2026-08-03T02:04:34.624671Z","2026-05-05T02:43:28.867675Z",{"nct_id":198,"title":199,"phases":200,"status":169,"updated_at":201,"content_modified":202},"NCT06608511","Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers",[],"2026-08-03T02:07:36.529363Z","2026-05-13T02:55:06.554644Z",[],[205,209,213,217,220,224,228,232,235,238],{"state":206,"count":207,"slug":208},"New York",10,"new-york",{"state":210,"count":211,"slug":212},"Florida",9,"florida",{"state":214,"count":215,"slug":216},"California",7,"california",{"state":218,"count":215,"slug":219},"Texas","texas",{"state":221,"count":222,"slug":223},"Ohio",6,"ohio",{"state":225,"count":226,"slug":227},"Georgia",4,"georgia",{"state":229,"count":230,"slug":231},"Maryland",3,"maryland",{"state":233,"count":230,"slug":234},"Michigan","michigan",{"state":236,"count":230,"slug":237},"Missouri","missouri",{"state":239,"count":230,"slug":240},"North Carolina","north-carolina"]